May 2021
The Global Clinical Trials Market is predicted to reach $77.20 billion by 2026, driven by the outbreak of tropical and infectious diseases and digitisation:
The first part of a two-part blog for Clinical Trials Day 2021, looking back at a year of COVID-19 studies registered at the ISRCTN registry, starting with the platform and repurposed drug treatment trials:
The second part of a two-part blog for Clinical Trials Day 2021, looking back at a year of COVID-19 studies registered at the ISRCTN registry, focusing on vaccine trials, testing and impacts on other conditions:
The safety and efficacy of both the Pfizer and AstraZeneca COVID-19 vaccines in a real-world community setting in the UK have proved to be even better than clinical trials predicted:
The European Medicines Agency (EMA) has announced that the clinical trial EU portal and database is now fully functional and on track to go live by 31 January 2022. The portal and database are one of the main deliverables of the 2014 Clinical Trial Regulation (Regulation (EU) No 536/2014), which was enforced to harmonise the assessment and supervision processes for clinical trials throughout the EU:
europeanpharmaceuticalreview.com
There are worrying sociodemographic disparities in cancer clinical trials, according to a new study from the University of Missouri School of Medicine, with people of colour, those with a higher income and younger individuals more likely to participate:
Drug trials need more participants. Research shows the potential benefits of changing the criteria used to determine who can enrol:
A FREE Webinar “Keeping standards high” about maintaining completion rates during vaccination rollout for COVID-19 is being held on 27 May at P.M. London/3M CET time. Sponsored by Nucleus Network, it will present strategies for ensuring reliable data while also maintaining the health and safety of trial participants:
The Q2/Matrix-M has become only the second malaria vaccine candidate ever to start a Phase III trial. It is the first malaria vaccine to reach the 75% efficacy target set by the WHO:
Seven trends and market changes affecting clinical trials in 2021: vaccine trials on the rise; Brexit; disruptions from the pandemic; increase in remote trials; personalised medicines; expanded access and post-trial monitoring; and digital transformation:
